The Department of Government Efficiency is continuing its work — even without its leader, Elon Musk, albeit now in a quieter ...

Pennsylvania State Sen. Tim Kearney and State Rep. Lisa Borowski introduced legislation addressing private equity and ...

Presented by The Coalition to Strengthen America’s Healthcare — A key anti-abortion group is pressuring a group of Senate ...

RFK Jr. is prepared to rework the FDA’s official assessment of the abortion pill mifepristone based at least in part on a questionable report.

Fired employees and conservatives say the gutted research teams’ work aligned with the Trump administration’s “pro-family” messaging.

A recent study conducted by the Ethics & Public Policy Center that found nearly 11% of women who used the popular abortion pill mifepristone experienced a “serious adverse event.” ...

The U.S. Department of Health and Human Services (HHS) is reviewing a hospital for compliance with federal conscience protections following reports that the hospital had denied ultrasound technicians ...

That kind of recommendation, known as shared decision-making, still means health insurers must pay for the vaccinations, ...

“I have asked Marty Makary, who is the director at FDA, to do a complete review and report back,” the HHS secretary revealed ... “largest-known” on the abortion pill – analyzed insurance ...

While the national spotlight often falls on state-level abortion bans or Supreme Court rulings, a quieter but more ...

The first 100 days of a new administration — while only a snapshot — can offer insight into the direction the rest of the ...

The FDA has been tasked with re-evaluating the safety of mifepristone after a flawed report claimed it has a high rate of ...